Hua-Jie Dong
Overview
Explore the profile of Hua-Jie Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong H, Li P, Wu C, Zhou X, Lu H, Zhou T
Lung Cancer
. 2016 Dec;
102:118-121.
PMID: 27987579
Approximately 10% of lung adenocarcinomas harbor aberrations that are targetable using the approved multitargeted TKI crizotinib. MET exon 14 skipping mutation predicts for response to crizotinib in human lung adenocarcinomas....
2.
Dong H, Fang C, Wang L, Fan L, Xu J, Wu J, et al.
Med Oncol
. 2014 Mar;
31(4):908.
PMID: 24615009
Previous studies have investigated the associations between TP53 mutations and codon 72 polymorphisms and prognosis in chronic lymphocytic leukemia (CLL). However, the joint effect of TP53 mutations and TP53 codon...
3.
Dong H, Ni L, Sheng G, Song H, Xu J, Ling Y
J Clin Virol
. 2013 Apr;
57(3):209-14.
PMID: 23562041
Background: The addition of Rituximab to standard chemotherapy (C) has been reported to improve the end of treatment outcome in non-Hodgkin lymphoma (NHL) patients. Nevertheless, rituximab has been associated with...
4.
Fang C, Dong H, Zou Z, Fan L, Wang L, Zhang R, et al.
Leuk Res
. 2013 Mar;
37(5):536-40.
PMID: 23453122
In order to determine the relationship between expression of cyclic nucleotide phosphodiesterase isoform 7B (PDE7B) and mantle cell lymphoma (MCL) progression, PDE7B mRNA expression was measured by qRT-PCR in 21...
5.
Dong H, Zhou L, Fang C, Fan L, Zhu D, Wang Y, et al.
Med Oncol
. 2011 Nov;
29(3):2166-73.
PMID: 22057359
Mantle cell lymphoma (MCL) is incurable in most patients. Several molecular markers have been identified as possible prognostic factors in MCL, including TP53 mutations. Direct sequencing was used to detect...
6.
Liu L, Fang C, Dong H, Wang D, Zhu D, Qiao C, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2011 Nov;
19(5):1145-9.
PMID: 22040960
This study was aimed to investigate the expression level of murine double minute 4 (MDM4) mRNA in chronic lymphocytic leukemia (CLL) and its prognostic value in CLL. By means of...
7.
Fang C, Zhu D, Dong H, Zhou Z, Wang Y, Liu L, et al.
Ann Hematol
. 2011 Oct;
91(4):553-9.
PMID: 21987025
MicroRNAs (miRNAs) are regulatory RNA molecules that are deregulated in many disease types, including cancer. Recently, miRNAs have shown promise as markers for cancer diagnosis. The aim of this study...
8.
Dong H, Fang C, Fan L, Zhu D, Wang D, Zhu H, et al.
Int J Cancer
. 2011 Jun;
130(9):2054-61.
PMID: 21647873
A single nucleotide polymorphism (SNP) at position 309 in the promoter region of MDM2 leading to increased expression of MDM2 and attenuated function of p53 has recently been suggested as...
9.
Cao X, Fan L, Fang C, Zhu D, Dong H, Wang D, et al.
Med Oncol
. 2011 Apr;
29(2):1190-6.
PMID: 21479697
SOX11 is mainly correlated with embryo neurogenesis and remodeling of tissues. D cyclins (cyclin D1, cyclin D2, and cyclin D3) work in cell transformation. We assessed the expression of SOX11,...
10.
Dong H, Miao K, Qiao C, Zhuang Y, Shen W, Hong M, et al.
Leuk Lymphoma
. 2011 Apr;
52(6):1003-9.
PMID: 21463115
The human multidrug resistance (MDR1, ABCB1) gene encodes P-glycoprotein (P-gp), which affects the pharmacokinetics of many drugs. Here, we investigated whether common MDR1 single nucleotide polymorphisms (SNPs) (C1236T, C3435T, and...